{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-018074","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2023-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.972392+00:00","generated_at":"2026-06-15T17:24:01.702163+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ginkgo Bioworks appoints Steven Coen as Chief Accounting Officer; Marie Fallon resigns","bullets":["Marie Fallon resigns as CAO effective May 15, 2023; she will remain through June 2 and then as consultant.","Steven Coen appointed CAO effective same date, with annual base salary of $400,000 and $1.5M equity grant vesting over 4 years.","Coen brings over 30 years experience, most recently Corporate VP & Controller at Charles River Laboratories (annual revenues ~$4B).","Fallon's resignation is personal, not due to any disagreement with the company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-018074","json":"https://secwatch.observer/filing/0000950170-23-018074.json","markdown":"https://secwatch.observer/filing/0000950170-23-018074.md","text":"https://secwatch.observer/filing/0000950170-23-018074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/0000950170-23-018074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/dna-20230501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T17:24:01.702163+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c085152b1f","claim":"Marie E. Fallon resigned as Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"Marie E. Fallon informed Ginkgo Bioworks Holdings, Inc. (the “Company”) on May 1, 2023 of her intent to resign from her role as Chief Accounting Officer of the Company, effective May 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/0000950170-23-018074-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"decfe4467f","claim":"Steven P. Coen was appointed as Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"In connection with Ms. Fallon’s resignation and subject to the approval of the Company’s Board of Directors, on May 5, 2023, the Company appointed Steven P. Coen, age 57, as its Chief Accounting Officer, effective May 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/0000950170-23-018074-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}